Serum Proteomic Profiling Reveals Differentially Expressed IGHG3 and A1AG1 as Potential Predictors of Chemotherapeutic Response in Advanced Non-small Cell Lung Cancer. Mon MM, Srisomsap C, Chokchaichamnankit D, Watcharatanyatip K, Weeraphan C, Svasti J, Maneechai K, Thongsuksai P, Raungrut P*. Anticancer Res. 2021 Apr;41(4):1871-1882.

01 Apr 2021
0
0

Serum Proteomic Profiling Reveals Differentially Expressed IGHG3 and A1AG1 as Potential Predictors of Chemotherapeutic Response in Advanced Non-small Cell Lung Cancer.

Mon MM, Srisomsap C, Chokchaichamnankit D, Watcharatanyatip K, Weeraphan C, Svasti J, Maneechai K, Thongsuksai P, Raungrut P*.

Anticancer Res. 2021 Apr;41(4):1871-1882.

Tags

Share this

Related Posts

Bacillus subtilis SSE4 produces subtulene A, a new lipopeptide antibiotic possessing an unusual C15 unsaturated beta-amino acid. Thasana N, Prapagdee B, Rangkadilok N, Sallabhan R, Aye SL, Ruchirawat S, Loprasert S FEBS Lett584p3209-14(2010 Jul 16)
28 Dec 2010
0

Bacillus subtilis SSE4 produces subtulene A, a new lipopeptide antibiotic possessing an unusual C15 unsaturated beta-amino acid. Thasana N, Prapagdee B, Rangkadilok N, Sallabhan R, Aye SL, Ruchirawat S, Loprasert S FEBS Lett584p3209-14(2010 Jul 16)

Bacillus subtilis SSE4 produces subtulene A, a new lipopeptide antibiotic possessing an unusual C15 unsaturated beta-amino acid. Thasana N, Prapagdee B, Rangkadilok N, Sallabhan R, Aye SL, Ruchirawat S, Loprasert S FEBS Lett584p3209-14(2010 Jul 16)
View More

Recent Posts